Dexcom, Inc. income statement & cash flow
In the fiscal year ended Dec 31, 2025, Dexcom, Inc. reported net income of $836.30M on revenue of $4.66B. Operating cash flow was $1.44B and capital expenditures were $363.50M, leaving $1.08B of free cash flow (operating cash flow minus capital expenditures).
Income statement and cash flow summary
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $573.30M | $718.50M | $1.03B | $1.48B | $1.93B | $2.45B | $2.91B | $3.62B | $4.03B | $4.66B |
| Gross profit | $378.40M | $492.10M | $663.90M | $931.50M | $1.28B | $1.68B | $1.88B | $2.29B | $2.44B | $2.80B |
| Operating income | −$63.90M | −$42.50M | −$186.30M | $142.30M | $299.50M | $265.80M | $391.20M | $597.70M | $600.00M | $911.80M |
| Net income | −$65.60M | −$50.20M | −$127.10M | $101.10M | $549.70M | $216.90M | $341.20M | $541.50M | $576.20M | $836.30M |
| Diluted EPS | — | −$0.58 | −$1.44 | $1.10 | $1.33 | $0.53 | $0.82 | $1.30 | $1.42 | $2.09 |
| Operating cash flow | $56.20M | $92.00M | $123.20M | $314.50M | $475.60M | $442.50M | $669.50M | $748.50M | $989.50M | $1.44B |
| Capital expenditures | $55.70M | $66.00M | $67.10M | $180.00M | $199.00M | $389.20M | $364.80M | $236.60M | $358.80M | $363.50M |
| Reported in | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 | 10-K 2026 |
Margins
Each figure divided by revenue for the same fiscal year.
| Fiscal year ended | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| Dec 2025 | 60.1% | 19.6% | 17.9% |
| Dec 2024 | 60.5% | 14.9% | 14.3% |
| Dec 2023 | 63.2% | 16.5% | 14.9% |
| Dec 2022 | 64.7% | 13.4% | 11.7% |
| Dec 2021 | 68.6% | 10.9% | 8.9% |
Source: SEC EDGAR XBRL company facts for CIK 1093557 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.